Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.99 AUD | -1.55% | +4.95% | +13.66% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.66% | 374M | |
+18.59% | 22.25B | |
+13.49% | 14.39B | |
+12.83% | 13.55B | |
+38.02% | 11.27B | |
-10.23% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.01B | |
-5.36% | 4.51B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma's Oral Contraceptive Pills Nextstellis Now Available in Australia